(S1 (S (NP (NP (DT The) (NN NF-kappa) (NN B) (NN precursor) (NN p105)) (CC and) (NP (NP (DT the) (NN proto-oncogene) (NN product)) (NP (NN Bcl-3)))) (VP (VP (VBP are) (NP (NN I) (NN kappa) (NN B) (NNS molecules))) (CC and) (VP (VBP control) (NP (NP (JJ nuclear) (NN translocation)) (PP (IN of) (NP (NN NF-kappa) (NN B)))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN examined) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (DT the) (NN NF-kappa) (NN B) (NN precursor) (NN p105))) (PP (IN with) (NP (NN NF-kappa) (NN B) (NNS subunits))))))) (. .)))
(S1 (S (S (ADVP (JJ Similar) (PP (TO to) (NP (DT an) (NN I) (NN kappa) (NN B) (NN molecule)))) (, ,) (NP (NN p105)) (VP (VBZ associates) (PP (IN in) (NP (DT the) (NN cytoplasm))) (PP (IN with) (NP (NP (NN p50)) (CC or) (NP (NN p65)))))) (. .)))
(S1 (S (S (PP (IN Through) (NP (DT this) (NN assembly))) (, ,) (NP (NN p105)) (ADVP (RB efficiently)) (VP (VBZ blocks) (NP (NP (JJ nuclear) (NN transfer)) (PP (IN of) (NP (DT either) (NN subunit)))))) (. .)))
(S1 (S (ADVP (RB Moreover)) (, ,) (NP (DT the) (NN p105) (NN protein)) (VP (VBZ inhibits) (NP (NP (NN DNA) (NN binding)) (PP (IN of) (NP (JJ dimeric) (NN NF-kappa) (NN B) (NNS subunits)))) (PP (IN in) (NP (DT a) (ADJP (ADJP (JJ similar)) (, ,) (CONJP (CC but) (RB not)) (ADJP (JJ identical)) (, ,)) (NN manner))) (PP (TO to) (NP (NP (PRP$ its) (VBN isolated) (JJ C-terminal) (NN domain)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ contains) (NP (NP (DT an) (JJ ankyrin-like) (NN repeat) (NN domain)) (PRN (-LRB- -LRB-) (NP (NN ARD)) (-RRB- -RRB-))))))))) (. .)))
(S1 (S (S (NP (DT The) (NN proto-oncogene) (NN product) (NN Bcl-3)) (ADVP (RB also)) (VP (VBZ controls) (NP (NP (JJ nuclear) (NN translocation)) (PP (PP (IN of) (NP (NN p50))) (, ,) (CC but) (PP (RB not) (IN of) (NP (NN p65))))))) (. .)))
(S1 (S (ADVP (RB Hence)) (, ,) (NP (NN p50)) (VP (MD can) (VP (VB be) (VP (VBN retained) (PP (IN in) (NP (DT the) (NN cytoplasm))) (PP (PP (IN via) (NP (QP (IN at) (JJS least) (CD three)) (JJ distinct) (NNS interactions))) (: :) (PP (IN through) (NP (JJ direct) (NNS interactions))) (CC either) (PP (IN with) (NP (PRP$ its) (JJ own) (NN precursor))) (, ,) (PP (IN with) (NP (NN Bcl-3))) (CC or) (ADVP (RB indirectly)) (PP (IN through) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha)) (CC or) (NP (NN -beta))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN attached) (PP (TO to) (NP (NN p65))))))))) (. .)))
(S1 (S (NP (PRP We)) (VP (VBP discuss) (NP (NP (DT a) (NN function)) (PP (IN of) (NP (NN p105))) (PP (IN as) (NP (DT a) (JJ cytoplasmic) (NN assembly) (NN unit))) (PP (PP (IN for) (NP (NP (NN homo-)) (CC and) (NP (JJ heteromeric) (NN NF-kappa) (NN B) (NNS complexes)))) (CC and) (PP (IN of) (NP (NN Bcl-3))))) (PP (IN as) (NP (NP (DT an) (NN I) (NN kappa) (NN B)) (PP (IN with) (NP (JJ novel) (NN subunit) (NN specificity)))))) (. .)))
